Comparing two drugs for poor responders in double ovarian stimulation
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial compares dydrogesterone with a GnRH antagonist to see which works better for women with a low number of eggs (poor responders) who are undergoing two rounds of egg retrieval in one cycle. It may help improve outcomes for those with specific fertility challenges.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been classified as a Poseidon group 4 patient, meaning you have a low number of eggs and are under 35 or over 35 with a diminished ovarian reserve.
- You are planning to have double ovarian stimulation (two egg retrievals in one menstrual cycle).
- You do not have polycystic ovary syndrome (PCOS).
- You do not have endometriosis.
- You have no history of repeated miscarriages.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving the hormone that triggers ovulation in two doses is better than one dose for people who over-respond to fertility treatment. It is designed for those having in vitro fertilization (IVF) with a GnRH antagonist protocol.
This trial tests two different ways to trigger the final maturation of eggs before retrieval in women who are considered poor responders to IVF treatment. It aims to see if a double trigger is more effective than the standard HCG trigger for improving egg and embryo outcomes.
This trial compares two different ways of stimulating the ovaries in women who have a poor response to fertility treatment. It aims to see which method gives a higher chance of having a live baby.
This study compares two methods of stimulating the ovaries before IVF: one using a standard hormone (hCG) and another using a different protocol. The goal is to see if the new method works as well as the standard one, while possibly being more cost-effective.
This study tests if a combination of two hormone drugs (follitropin alfa/lutropin alfa) works as well as another drug (hMG) for Japanese women with low LH and FSH levels who are doing in vitro fertilization (IVF). The goal is to help them produce eggs for pregnancy.
This study compares two different hormone medication protocols for women with low ovarian reserve who are undergoing IVF with a freeze-all approach. The goal is to see which protocol leads to better egg and embryo development.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.